Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The BMAL1-CLOCK complex is a heterodimeric transcription factor that serves as the master regulator of the mammalian circadian rhythm. It consists of the Brain and Muscle ARNT-Like Protein 1 (BMAL1) and the Circadian Locomotor Output Cycles Kaput (CLOCK) protein, both members of the basic helix-loop-helix-PAS (bHLH-PAS) family. The complex binds to E-box regulatory elements (CACGTG) in the promoters of clock-controlled genes (CCGs) to initiate the expression of the Period (PER) and Cryptochrome (CRY) proteins, which in turn provide negative feedback by inhibiting the activity of the BMAL1-CLOCK complex. Beyond its role as a molecular timekeeper, this complex regulates approximately 10-15% of the transcriptome, influencing key processes such as glucose and lipid metabolism, cell cycle progression, and the immune response. \n\nDysregulation of the BMAL1-CLOCK pathway is a hallmark of several pathologies, including metabolic syndrome, sleep-wake cycle disorders, and various cancers, where it can act as either a tumor suppressor or an oncogene depending on the tissue context. In drug discovery, the complex is targeted using small-molecule modulators aimed at restoring homeostatic rhythmicity or suppressing disease-related gene expression. Emerging compounds like Core Circadian Modulators (CCMs) target specific pockets in the PAS domains to stabilize the heterodimer or prevent repressor binding. Additionally, indirect modulation via ROR or REV-ERB receptors is frequently explored to treat metabolic and inflammatory conditions associated with circadian misalignment.
Modulation of BMAL1-CLOCK transcription factor activity through direct binding to PAS-B domains or stabilization of the heterodimer to restore circadian gene expression patterns and enhance the amplitude of biological oscillations.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Brain and muscle ARNT-like protein 1-Circadian locomotor output cycles kaput complex (BMAL1-CLOCK complex) (BMAL1-CLOCK).